Mary Kerr MD KaNDy Therapeutics guest speaker at a recent Labiotech meeting in London

Press Release: KaNDy Therapeutics launched to focus on a breakthrough new product in Women’s Health

First-in-class once daily NT-814 spun out of NeRRe Therapeutics into new company   Stevenage, UK, 27th September 2017 – KaNDy Therapeutics has been launched today to maximise the value [...]